Egypt is the most populous Arab country in the world and has a growing population rate. The demand for healthcare services is expected to grow continuously with Egypt requiring an additional 26,000 beds (at 1.5 beds / 1,000 population) with an investment of $6 billion to $9 billion. Dr Soliman highlights the healthcare investment opportunities.
In the Middle East, the growth of palliative care is still in its early stages. Dr Lama El Zein discusses how providing palliative care has shown to have extensive benefits for patients with serious illnesses by improving quality of life, decreasing unnecessary cost and improving care throughout the illness.
Professor Samar Ahmed highlights a stand-alone workplace culture crisis within Health Professions Schools. She discusses how faculty in these schools are burdened with the responsibility to build graduates who are willing to work under extreme stress and yet remain empathic and human. Dr Samar Ahmed provides a range of solutions to address the workplace culture crisis.
A large majority of people will experience back pain at some point in their lives. It is estimated that 540 million people globally are affected by low back pain and it is the main cause of disability worldwide. A peer-reviewed research study concluded that the highest prevalence of low back pain is in Western Europe, followed by the MENA region
Urine testing may be as effective as the smear test at preventing cervical cancer, according to a study published in the journal BMJ Open.
The thalassemia syndromes are genetic disorders characterized by absent or deficient synthesis of one or more of the normal globin chains. Biotechnologist Osama Atif provides an overview of these gentic disorders.
According to the paper now available online, TP53 is the most frequently mutated gene in triple negative breast cancer, meaning it is fuelling the growth of this aggressive form of breast cancer. However, the problem with trying to target mutated TP53, specifically, is that it is not a druggable target, because of its potential toxicity – or ability to kill – nearby healthy cells.
Vasopressors are medications that causes vasoconstriction; some of them have additional inotropic effect. By maintaining end-organ perfusion; the role of vasopressors remains critical to prevent irreversible organ injury and failure, and their use is usually accompanied by fluid resuscitation for adequate patient outcomes. Vasopressor agents are used clinically in the treatment of arterial hypotension in shock states. Shock is best defined as inadequate blood flow to meet the metabolic needs of the tissues. The most common reasons for shock are the cardiac output is low relative to the global demand, despite increased O2 extraction by the tissues; or perfusion pressure is inadequate such that blood flow distribution to metabolically active tissues is inadequate, despite an otherwise adequate cardiac output.